Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00694759 · ClinicalTrials.gov registry record · NA
Cortisol Regulation in Polycystic Ovary Syndrome (PCOS)
A NA study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT00694759 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 37 participants.
The verdict
NCT00694759, a NA study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if insulin resistance (how well the body uses insulin and clears sugar) can affect cortisol levels in normal healthy women and women with polycystic ovary syndrome of all body weights.
Interventions
- DRUG placebo
- DRUG metformin
- DRUG pioglitazone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2006-10 |
| Est. Completion | 2011-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00694759
The ClinicalTrials.gov registry entry for NCT00694759 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00694759 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00694759 about?
NCT00694759 is a clinical study titled "Cortisol Regulation in Polycystic Ovary Syndrome (PCOS)". The purpose of this study is to determine if insulin resistance (how well the body uses insulin and clears sugar) can affect cortisol levels in normal healthy women and women with polycystic ovary syndrome of all body weights.
What is the current status of trial NCT00694759?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2006-10. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00694759?
The interventions under investigation include: placebo (DRUG), metformin (DRUG), pioglitazone (DRUG).
Who is sponsoring clinical trial NCT00694759?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.